The Secretary of State for Trade and Industry Patricia Hewitt today announced the go-head for a new £30 million manufacturing centre for biosciences, which could bring 1,000 new jobs to Liverpool.
National Biomanufacturing Centre will be a 3,250 sq m facility based at the Estuary Business Park in Speke, Liverpool, and will consist of three laboratories and a production plant.
A £9.74 million grant has been agreed from Merseyside’s Objective One programme for the National Biomanufacturing Centre and £3 million has already invested been by the Department of Trade and Industry (DTI). The majority of the remaining funding will come from the Northwest Development Agency (NWDA).
According to a statement, up to 1,000 new jobs could be created by the facility, which will cement Merseyside’s position as the national hub of biomanufacturing with over 25 companies involved in the £2 billion sector already based in the region.
‘Merseyside has always been a historical centre of excellence for traditional forms of manufacturing,’ said Hewitt. ‘This new biosciences centre will help the area develop its reputation in modern, science rich manufacturing.”
Biomanufacturing is the creation of cultures, tissues and microbes for use in pharmaceutical research. Although Britain has a strong science skills base, smaller companies, universities, hospitals and research institutions are held back by a shortage of trial production facilities.
The new centre, to be operated by Eden BioDesign, will offer specialist biomanufacturing services to organisations without the capacity to deliver large orders.
More than 100 temporary construction jobs will be created while the facility is built. Although the centre will employ only 74 staff directly, it is estimated that a further 850 jobs will be created by companies investing in Merseyside as a result of the new centre.